Genetic hallmarks of recurrent/metastatic adenoid cystic carcinomaAllen S. Ho, Luc G.T. Morris, Alan L. Ho et al.|Journal of Clinical Investigation|2019Cited by 210
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancerMichalina Janiszewska, Kornélia Polyák, Lin Liu et al.|Nature Genetics|2015Cited by 166
Epigenetic dysregulation from chromosomal transit in micronucleiAlbert S. Agustinus, Samuel F. Bakhoum, Duaa H. Al-Rawi et al.|Nature|2023Cited by 118
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancerMothaffar F. Rimawi, Rachel Schiff, Carmine De Angelis et al.|Breast Cancer Research and Treatment|2017Cited by 95
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without ChemotherapyCarmine De Angelis, Rachel Schiff, Chandandeep Nagi et al.|Clinical Cancer Research|2019Cited by 87